JP2018502117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502117A5 JP2018502117A5 JP2017535420A JP2017535420A JP2018502117A5 JP 2018502117 A5 JP2018502117 A5 JP 2018502117A5 JP 2017535420 A JP2017535420 A JP 2017535420A JP 2017535420 A JP2017535420 A JP 2017535420A JP 2018502117 A5 JP2018502117 A5 JP 2018502117A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- cells
- composition
- selectin ligand
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021169444A JP7339990B2 (ja) | 2014-12-30 | 2021-10-15 | 細胞療法を改善するための方法 |
| JP2023137151A JP2023156522A (ja) | 2014-12-30 | 2023-08-25 | 細胞療法を改善するための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098048P | 2014-12-30 | 2014-12-30 | |
| US62/098,048 | 2014-12-30 | ||
| US201562101863P | 2015-01-09 | 2015-01-09 | |
| US62/101,863 | 2015-01-09 | ||
| PCT/US2015/067873 WO2016109543A1 (en) | 2014-12-30 | 2015-12-29 | Methods to improve cell therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021169444A Division JP7339990B2 (ja) | 2014-12-30 | 2021-10-15 | 細胞療法を改善するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502117A JP2018502117A (ja) | 2018-01-25 |
| JP2018502117A5 true JP2018502117A5 (https=) | 2019-02-14 |
| JP6963500B2 JP6963500B2 (ja) | 2021-11-10 |
Family
ID=55299731
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017535420A Active JP6963500B2 (ja) | 2014-12-30 | 2015-12-29 | 細胞療法を改善するための方法 |
| JP2021169444A Active JP7339990B2 (ja) | 2014-12-30 | 2021-10-15 | 細胞療法を改善するための方法 |
| JP2023137151A Pending JP2023156522A (ja) | 2014-12-30 | 2023-08-25 | 細胞療法を改善するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021169444A Active JP7339990B2 (ja) | 2014-12-30 | 2021-10-15 | 細胞療法を改善するための方法 |
| JP2023137151A Pending JP2023156522A (ja) | 2014-12-30 | 2023-08-25 | 細胞療法を改善するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10471103B2 (https=) |
| EP (2) | EP3240893B1 (https=) |
| JP (3) | JP6963500B2 (https=) |
| KR (2) | KR20230127358A (https=) |
| CN (2) | CN107249601A (https=) |
| AU (2) | AU2015374198B2 (https=) |
| BR (1) | BR112017014361B1 (https=) |
| CA (2) | CA3202385A1 (https=) |
| ES (1) | ES3051035T3 (https=) |
| HK (1) | HK1245132A1 (https=) |
| SG (2) | SG11201705401YA (https=) |
| WO (1) | WO2016109543A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102396838B1 (ko) * | 2016-05-20 | 2022-05-11 | 로버트 색스테인 | E-셀렉틴 리간드의 당조작 |
| JP7637323B2 (ja) * | 2016-06-23 | 2025-02-28 | ティソン バイオテック，インコーポレイテッド | 副甲状腺ホルモン１型受容体を発現する細胞およびその使用 |
| EP4417210A1 (en) | 2017-03-15 | 2024-08-21 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| EP3773629A4 (en) | 2018-03-27 | 2022-01-19 | AZTherapies, Inc. | CAR-TREG-BASED THERAPIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| US20210154230A1 (en) * | 2018-05-04 | 2021-05-27 | Spinalcyte, Llc | Intradiscal t-regulatory cell administration for treatment of disc degenerative disease |
| CN108642004A (zh) * | 2018-05-17 | 2018-10-12 | 广东芙金干细胞再生医学有限公司 | 一种外泌体的制备方法及含有外泌体的干细胞增殖试剂 |
| WO2019245904A1 (en) * | 2018-06-18 | 2019-12-26 | The Brigham And Women's Hospital | Compositions and methods for production of exofucosylated cells for clinical applications |
| TW202043463A (zh) * | 2018-12-14 | 2020-12-01 | 比利時商普羅米修亞生物科技股份有限公司 | 包含表現hla-e之肝先驅細胞之細胞組成物 |
| WO2020224450A1 (en) * | 2019-05-03 | 2020-11-12 | The University Of Hong Kong | Method for peritoneal metastatic cell detection and isolation thereof |
| EP4153616A4 (en) * | 2020-05-18 | 2024-08-21 | Robert Sackstein | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| TWI883563B (zh) * | 2022-09-30 | 2025-05-11 | 中國醫藥大學 | 細胞植體與類膠原蛋白之多功能胜肽組合物及其應用 |
| EP4649140A1 (en) * | 2023-01-13 | 2025-11-19 | The Brigham and Women's Hospital | Compositions and methods for identifying and isolating human hematopoietic stem and progenitor cells |
| WO2026010977A1 (en) * | 2024-07-01 | 2026-01-08 | Robert Sackstein | Compositions and methods for treatment of human diseases with glycocalyx-modified mesenchymal stem cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU782952C (en) * | 1999-08-25 | 2006-09-07 | Altarex Medical Corp. | Therapeutic immune condition compositions and methods |
| JP4198990B2 (ja) | 2000-10-18 | 2008-12-17 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 造血細胞のｅ−セレクチン／ｌ−セレクチンリガンドポリペプチドおよびその使用法 |
| BRPI0513897A (pt) * | 2004-07-29 | 2008-05-20 | Stem Cell Innovations Inc | diferenciação de células-tronco |
| WO2006068720A2 (en) | 2004-11-12 | 2006-06-29 | The Brigham And Women's Hospital, Inc. | Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| US20070003528A1 (en) * | 2005-06-29 | 2007-01-04 | Paul Consigny | Intracoronary device and method of use thereof |
| AU2007243221A1 (en) * | 2006-04-28 | 2007-11-08 | Tulane University Health Sciences Center | Methods for treating diabetes |
| EP3336174A1 (en) * | 2006-06-02 | 2018-06-20 | Robert Sackstein | Compositions and methods for modifying cell surface glycans |
| US7998740B2 (en) * | 2006-07-18 | 2011-08-16 | Robert Sackstein | Cytokine induction of selectin ligands on cells |
| WO2009134866A2 (en) | 2008-04-29 | 2009-11-05 | The Brigham And Women's Hospital, Inc. | Cell membrane engineering |
| US20140161782A1 (en) * | 2008-06-09 | 2014-06-12 | Targazyme, Inc. | Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferase |
| WO2011068909A2 (en) | 2009-12-01 | 2011-06-09 | Brigham And Women's Hospital, Inc. | Aptamer cell compositions |
| CA2954534C (en) * | 2014-07-07 | 2023-04-04 | Targazyme, Inc. | Manufacture and cryopreservation of fucosylated cells for therapeutic use |
-
2015
- 2015-12-29 SG SG11201705401YA patent/SG11201705401YA/en unknown
- 2015-12-29 EP EP15831197.7A patent/EP3240893B1/en active Active
- 2015-12-29 BR BR112017014361-5A patent/BR112017014361B1/pt active IP Right Grant
- 2015-12-29 KR KR1020237028021A patent/KR20230127358A/ko not_active Ceased
- 2015-12-29 KR KR1020177021422A patent/KR102569540B1/ko active Active
- 2015-12-29 JP JP2017535420A patent/JP6963500B2/ja active Active
- 2015-12-29 CN CN201580076144.8A patent/CN107249601A/zh active Pending
- 2015-12-29 US US14/982,863 patent/US10471103B2/en active Active
- 2015-12-29 AU AU2015374198A patent/AU2015374198B2/en active Active
- 2015-12-29 ES ES21193478T patent/ES3051035T3/es active Active
- 2015-12-29 WO PCT/US2015/067873 patent/WO2016109543A1/en not_active Ceased
- 2015-12-29 SG SG10202013095YA patent/SG10202013095YA/en unknown
- 2015-12-29 HK HK18104812.8A patent/HK1245132A1/zh unknown
- 2015-12-29 EP EP21193478.1A patent/EP4012024B1/en active Active
- 2015-12-29 CA CA3202385A patent/CA3202385A1/en active Pending
- 2015-12-29 CA CA2972899A patent/CA2972899C/en active Active
- 2015-12-29 CN CN202310228900.0A patent/CN116327805A/zh active Pending
-
2019
- 2019-11-08 US US16/678,929 patent/US20200281985A1/en not_active Abandoned
-
2021
- 2021-10-15 JP JP2021169444A patent/JP7339990B2/ja active Active
-
2022
- 2022-03-03 AU AU2022201482A patent/AU2022201482A1/en not_active Abandoned
- 2022-11-10 US US18/054,364 patent/US12090173B2/en active Active
-
2023
- 2023-08-25 JP JP2023137151A patent/JP2023156522A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502117A5 (https=) | ||
| Henning et al. | Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size | |
| Kenmuir et al. | Update on cell therapy for stroke | |
| Oneto et al. | Implantable biomaterial based on click chemistry for targeting small molecules | |
| Bansal et al. | Autologous bone marrow-derived stem cells in spinal cord injury | |
| US11351190B2 (en) | Composition for treating tissue lesions | |
| JPS6256440A (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| García‐Bosch et al. | Stem cell therapies for inflammatory bowel disease–efficacy and safety | |
| Varadi et al. | Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma | |
| JP2022519196A5 (https=) | ||
| Fisher et al. | Effect of antilymphocyte serum on parameters of tumor growth in a syngeneic tumor-host system | |
| WO2019230859A1 (ja) | 変形性関節症の処置および／または予防方法 | |
| US20210346317A1 (en) | Treatment of hematopoietic stem cell transplant patients | |
| CN104434908B (zh) | 山奈酚在抑制受体对器官移植排斥反应药物中的应用 | |
| CN105030749B (zh) | 丙戊酸钠在制备预防和治疗移植物抗宿主病药物中的应用 | |
| CN111494711B (zh) | 干细胞发生器产生的干细胞用于治疗造血损伤 | |
| KR20130023797A (ko) | 자연살해세포 억제제 및 간엽줄기세포를 유효성분으로 포함하는 이식편대숙주질환의 예방 또는 치료를 위한 세포치료제 조성물 | |
| Agius et al. | Medical applications of stem cell technology in diseases of blood and the circulatory system | |
| Kim et al. | Case report of amniotic membrane derived-stem cells treatment for feline chronic obstructive pulmonary disease | |
| DORTAJ et al. | NOVEL DRUG DELIVERY FOR TREATING CARTILAGE INJURIES | |
| Obando et al. | Cell regeneration medicine in case of salih myopathy and hypoxic encephalopathy | |
| WO2023056075A1 (en) | Compositions and methods for reduced toxicity in transplantation using janus kinase (jak) inhibitors | |
| Ju et al. | Received November 23, 2021 Revised December 7, 2021 Accepted December 8, 2021 | |
| US20100098671A1 (en) | composition for prevention or treatment of bone marrow damage | |
| Sanna et al. | Case Report Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation |